Tumour Virus Research

Aims & Scope

Tumour Virus Research aims to publish primary research and review articles covering all aspects of virally driven neoplasia, ranging from basic molecular and cancer virology including virus-associated tumour models, diagnostics, vaccines, and therapies, through to clinical, epidemiological, and public awareness aspects.

This open access journal is a forum for cross disciplinary work in tumour virus research and looks to build upon the expertise and unique insights that the study of different viruses can bring to the fields of cancer prevention and therapy."

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology and Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,360.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Cervical cancer therapies: Current challenges and future perspectives

  Citation: 325

  Authors: Carly A., Saif F., Georgia, Nomonde, Tracey, Jennifer, Sharon

• Human papillomavirus E6 and E7: What remains?

  Citation: 108

  Authors: Arushi, Oscar, Miranda, Lawrence

• Human papillomavirus genomics: Understanding carcinogenicity

  Citation: 92

  Authors: Chase W., Lisa

• HPV and head and neck cancers: Towards early diagnosis and prevention

  Citation: 53

  Authors: Luisa, Susanna, Daria, Marta, Cindy, Tarik, Marc, Massimo

• Construction of a diagnostic model for hepatitis B-related hepatocellular carcinoma using machine learning and artificial neural networks and revealing the correlation by immunoassay

  Citation: 51

  Authors: Shengke, Chenglu, Lai, Haiqing, Jinbang, Xinrui, Zhijia, Lisa Jia, Jing, Hao, Guanhu, Gang

• Epstein-Barr virus: Current questions and challenges

  Citation: 36

  Authors: Lori

• Merkel cell polyomavirus and associated Merkel cell carcinoma

  Citation: 31

  Authors: June F., Jianxin

• The human Papillomavirus twilight zone – Latency, immune control and subclinical infection

  Citation: 29

  Authors: John

• Development and evaluation of an online continuing education course to increase healthcare provider self-efficacy to make strong HPV vaccine recommendations to East African immigrant families

  Citation: 23

  Authors: SarahAnn M., Linda K., Megha, Anisa, Debra, John, Farah B., Fanaye, Ahmed A., Sou Hyun, Rachel L.

• Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and HIV-negative adults

  Citation: 22

  Authors: James, Andrew F., Heather M., Lora P., Rafael, Marisa C., Emily C., Rachel L., Monica L., Jodi K., Trey B., Suiyuan, Robert L., Dong Moon, Carole, Thomas, Daniel, Ashley, Thomas E., Nicolas F.